About Longeviti Neuro Solutions
Longeviti Neuro Solutions is a private company based in Hunt Valley, Maryland. It has reported $22,959,385 raised in six offerings on Form D since July 2019. Its chief executive is Jesse Christopher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 30, 2024 | Jan 8, 2025 | $1,221,921of $7.0M target | 2 | $610K | EquityRule 506(b) | Form D ↗ |
| Oct 31, 2023 | Nov 1, 2023 | $750,000of $2.9M target | 1 | $750K | EquityRule 506(b) | Form D ↗ |
| Apr 19, 2023 | May 3, 2023 | $1,181,827fully sold | 15 | $78,788 | EquityRule 506(b) | Form D ↗ |
| Dec 14, 2021 | Jan 26, 2022 | $4,753,310of $6.0M target | 21 | $226K | EquityRule 506(b) | Form D ↗ |
| Aug 14, 2020 | Aug 24, 2020 | $5,462,584of $8.0M target | 23 | $237K | EquityRule 506(b) | Form D ↗ |
| Jun 21, 2019 | Jul 1, 2019 | $9,589,743of $12.5M target | 39 | $245K | Equity, DebtRule 506(b) | Form D ↗ |
| Total, six offerings | $22,959,385 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Longeviti Neuro Solutions's Form D filed Jan 8, 2025.
GC
JP
John Parker
Director
JC
Jesse Christopher
Chief Executive Officer and director
JK
Jill Kalmann
Director
Earlier filings also listed Lewis Parker (director, last listed Nov 2023), John Andres (director, last listed Nov 2023), Jill Kalman (director, last listed Nov 2023), Matthew Swartz (director, last listed Aug 2020) and Chad Gordon (director, last listed Aug 2020).